All Stories

  1. A Researcher’s guide to rodent models of Down syndrome: Recent insights and translational perspectives
  2. 64Cu Hypoxia Imaging Radiotracer Targeting the Human Copper Transporter
  3. Dural Ectopic Lymphatic Structures Accumulate During Aging and are Dysregulated in Neurodegenerative Diseases
  4. Fetomaternal transfer during Down Syndrome pregnancies induces maternal cognitive decline in an APP‐dependent manner
  5. Uncovering Shared and Tissue-Specific Molecular Adaptations to Intermittent Fasting in Liver, Brain, and Muscle
  6. Dural ectopic lymphatic structures accumulate during aging and exhibit dysregulation in neurodegenerative diseases
  7. Uncovering Shared and Tissue-Specific Molecular Adaptations to Intermittent Fasting in Liver, Brain, and Muscle
  8. Intermittent Fasting Reprograms Chromatin Accessibility to Modulate Gene Expression in Brain and Muscle
  9. CD8+ T cells exacerbate AD-like symptoms in mouse model of amyloidosis
  10. Unbiased analysis of spatial learning strategies in a modified Barnes maze using convolutional neural networks
  11. Unraveling the molecular basis of cannabidiolic acid methyl Ester's anti-depressive effects in a rat model of treatment-resistant depression
  12. Neuronal deletion of Gtf2i results in developmental microglial alterations in a mouse model related to Williams syndrome
  13. Neural correlates of subjective cognitive decline in adults at high risk for Alzheimer’s disease
  14. Early diagnosis and treatment of Alzheimer’s disease by targeting toxic soluble Aβ oligomers
  15. Corrigendum to “Physiology and pharmacology of amyloid precursor protein” [Pharmacology & Therapeutics Volume 235(2022) 108122
  16. Sleeve Gastrectomy Reduces Glycemia but Does Not Affect Cognitive Impairment in Lean 5xFAD Mice
  17. Physiology and pharmacology of amyloid precursor protein
  18. HCAR1-Mediated l-Lactate Signaling Suppresses Microglial Phagocytosis
  19. Integrative epigenomic and transcriptomic analyses reveal metabolic switching by intermittent fasting in brain
  20. COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated
  21. Induction of an effective anti-Amyloid-β humoral response in aged mice
  22. Immune Dysregulation and the Increased Risk of Complications and Mortality Following Respiratory Tract Infections in Adults With Down Syndrome
  23. Correction to: Specific Susceptibility to COVID-19 in Adults with Down Syndrome
  24. Adult Hippocampal Neurogenesis: One Lactate to Rule Them All
  25. Therapeutic B-cell depletion reverses progression of Alzheimer’s disease
  26. Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis
  27. Specific Susceptibility to COVID-19 in Adults with Down Syndrome
  28. High-Intensity Functional Training: Molecular Mechanisms and Benefits
  29. Mild Physical Activity Does Not Improve Spatial Learning in a Virtual Environment
  30. Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity
  31. Maternal antibodies facilitate Amyloid-β clearance by activating Fc-receptor-Syk-mediated phagocytosis
  32. The Effects of High-intensity Functional Training (HIFT) on Spatial Learning, Visual Pattern Separation and Attention Span in Adolescents
  33. A Tellurium-Based Small Immunomodulatory Molecule Ameliorates Depression-Like Behavior in Two Distinct Rat Models
  34. Food and Age: It Takes Two to Degenerate
  35. Integrative Epigenomic and Transcriptomic Analysis Reveals Robust Metabolic Switching in the Brain During Intermittent Fasting
  36. A modified Barnes maze for an accurate assessment of spatial learning in mice
  37. L-Lactate Promotes Adult Hippocampal Neurogenesis
  38. Extracellular DAMPs in Plants and Mammals: Immunity, Tissue Damage and Repair
  39. The Toll Pathway in the Central Nervous System of Flies and Mammals
  40. Restoring microglial and astroglial homeostasis using DNA immunization in a Down Syndrome mouse model
  41. Dopamine receptors in the rat entopeduncular nucleus
  42. Deficiency of Toll-like receptors 2, 3 or 4 extends life expectancy in Huntington’s disease mice
  43. A protocol for quantitative analysis of murine and human amyloid-β1-40 and 1-42
  44. Dopaminergic Modulation of Synaptic Integration and Firing Patterns in the Rat Entopeduncular Nucleus
  45. Sirt6 alters adult hippocampal neurogenesis
  46. The Effect of Nanoparticle Size on the Ability to Cross the Blood–Brain Barrier: An In Vivo Study
  47. Toll-like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE-induced epilepsy in mice
  48. Unbiased classification of spatial strategies in the Barnes maze
  49. Inflammation, Lifestyle and Chronic Diseases
  50. Unraveling cognitive traits using the Morris water maze unbiased strategy classification (MUST-C) algorithm
  51. Corrigendum to “Unraveling cognitive traits using the Morris water maze unbiased strategy classification (MUST-C) algorithm” [Brain Behav. Immun. 52C (2016) 132–144]
  52. DAMPs as mediators of sterile inflammation in aging-related pathologies
  53. Postnatal TLR2 activation impairs learning and memory in adulthood
  54. No ECSIT-stential evidence for a link with Alzheimer's disease yet (retrospective on DOI 10.1002/bies.201100193)
  55. Cardiovascular Fitness and Cognitive Spatial Learning in Rodents and in Humans
  56. Toll-like receptors as developmental tools that regulate neurogenesis during development: an update
  57. Pancreatic polypeptide inhibits somatostatin secretion
  58. A heavy toll on the outcome of ischemic brain stroke
  59. Toll-like receptors 2 and 4 modulate autonomic control of heart rate and energy metabolism
  60. Evidence that collaboration between HIF-1α and Notch-1 promotes neuronal cell death in ischemic stroke
  61. Tellurium Compound AS101 Ameliorates Experimental Autoimmune Encephalomyelitis by VLA-4 Inhibition and Suppression of Monocyte and T Cell Infiltration into the CNS
  62. Opposing actions of environmental enrichment and Alzheimer’s disease on the expression of hippocampal microRNAs in mouse models
  63. A ketone ester diet exhibits anxiolytic and cognition-sparing properties, and lessens amyloid and tau pathologies in a mouse model of Alzheimer's disease
  64. Neuron-Specific Expression of Tomosyn1 in the Mouse Hippocampal Dentate Gyrus Impairs Spatial Learning and Memory
  65. Dietary energy intake modifies brainstem autonomic dysfunction caused by mutant α-synuclein
  66. Effects of cerium oxide nanoparticles on the growth of keratinocytes, fibroblasts and vascular endothelial cells in cutaneous wound healing
  67. Involvement of PGC-1α in the formation and maintenance of neuronal dendritic spines
  68. Evidence for a Developmental Role for TLR4 in Learning and Memory
  69. Aberrant heart rate and brainstem brain-derived neurotrophic factor (BDNF) signaling in a mouse model of Huntington's disease
  70. The Tellurium compound, AS101, increases SIRT1 level and activity and prevents type 2 diabetes
  71. DNA immunization with HBsAg-based particles expressing a B cell epitope of amyloid β-peptide attenuates disease progression and prolongs survival in a mouse model of Alzheimer's disease
  72. Roles of Innate Immunity and Inflammation in the Aging Brain
  73. Toll-like receptor signaling in neural plasticity and disease
  74. Evidence for Altered Numb Isoform Levels in Alzheimer's Disease Patients and a Triple Transgenic Mouse Model
  75. Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice
  76. Electroconvulsive shock ameliorates disease processes and extends survival in huntingtin mutant mice
  77. GLP-1 receptor stimulation depresses heart rate variability and inhibits neurotransmission to cardiac vagal neurons
  78. Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis
  79. Evidence that adiponectin receptor 1 activation exacerbates ischemic neuronal death
  80. TLR2 activation inhibits embryonic neural progenitor cell proliferation
  81. Tomosyn Expression Pattern in the Mouse Hippocampus Suggests Both Presynaptic and Postsynaptic Functions
  82. Involvement of Fc Receptors in Disorders of the Central Nervous System
  83. The Therapeutic Potential of microRNAs in Nervous System Damage, Degeneration, and Repair
  84. Adhesion- and migration-related side effects of phosphothioated CpG oligodeoxynucleotides
  85. TOLL-LIKE RECEPTORS IN ISCHEMIA-REPERFUSION INJURY
  86. Toll-like receptors in neurodegeneration
  87. Phosphothioated oligodeoxynucleotides induce nonspecific effects on neuronal cell adhesion in a growth substrate‐dependent manner
  88. Neuronal Vulnerability to Oxidative Damage in Aging
  89. Basis of Ionic Dysregulation in Cerebral Ischemia
  90. Rapamycin and curcumin induce apoptosis in primary resting B chronic lymphocytic leukemia cells
  91. Monoamines, BDNF, Dehydroepiandrosterone, DHEA-Sulfate, and Childhood Depression—An Animal Model Study
  92. Toll-Like Receptor 3 Is a Negative Regulator of Embryonic Neural Progenitor Cell Proliferation
  93. The organotellurium compound ammonium trichloro(dioxoethylene‐o,o′)tellurate reacts with homocysteine to form homocystine and decreases homocysteine levels in hyperhomocysteinemic mice
  94. Synergistic effect of AS101 and Bryostatin-1 on myeloid leukemia cell differentiation in vitro and in an animal model
  95. The organotellurium compound ammonium trichloro(dioxoethylene‐0,0′) tellurate enhances neuronal survival and improves functional outcome in an ischemic stroke model in mice
  96. Novel Involvement of the Immunomodulator AS101 in IL‐10 Signaling, via the Tyrosine Kinase Fer
  97. Gamma secretase–mediated Notch signaling worsens brain damage and functional outcome in ischemic stroke
  98. Experimental handling stress as infection-facilitating factor for the goldfish ulcerative disease
  99. Upregulation of carp GDNF mRNA by the immunomodulator AS101